|
Faculty | |
Statement of Need | |
Learning Objectives | |
Financial Support | |
Target Audience | |
Credit Information |
More Than Hair Loss: Global Perspectives on the Clinical Diagnosis and Management of Alopecia Areata
Premiere Date: Thursday, June 16, 2022This activity offers CE credit for:
%>- ABIM (MOC)
- Medicine (accme)
- Nursing (ANCC)
- PA (aapa)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Friday, June 16, 2023
Note: Credit Is No Longer Available
Nekma Meah, MBChB, MRCP (UK), MRCP (Derm), FACD Honorary Secretary, British Hair and Nail Society Consultant Dermatologist BMI The Beardwood Hospital Blackburn, UK |
Dmitri Wall, MB BCh BAO, MRCP (UK), MSc (Faculty) Assistant Professor Charles Institute of Dermatology University College Dublin School of Medicine Hair Restoration Blackrock Dublin, Ireland |
Alopecia areata (AA) is an immune-mediated disorder causing patchy hair loss on the scalp, face, or body. It is associated with several comorbidities including depression, anxiety, and additional autoimmune diseases. The frequency of concurrent conditions and overall symptomatology of AA differs among geographically separate populations, suggesting a genetically variable etiology. To form an appropriate differential diagnosis, clinicians must be able to recognize clinical manifestations and disease severity among diverse subtypes of AA.
Join Drs. Nekma Meah and Dmitri Wall for the second installment of this three-part virtual Journal Club series as they discuss the clinical manifestations of AA and associated autoimmune disorders in different patient populations.
At the end of this CE activity, participants should be able to:
- Explain the clinical manifestations of alopecia areata.
Supported by an educational grant from Pfizer Inc.
Physicians, PAs, and nurse practitioners specializing in dermatology, allergy/immunology, general practice, and/or pediatrics located outside of the United States
EACCME:
Through a mutual recognition agreement between the AMA and the UEMS-EACCME, European physicians completing an e-learning activity from a US-based ACCME-accredited CME provider can use AMA PRA Category 1 Credit™ toward their credit requirements. CME Outfitters is based in Radnor, Pennsylvania, USA. Please retain your certificate as proof of completion.
Qatar:
Through a mutual recognition agreement between the AMA and the DHP, physicians licensed in Qatar completing an activity from a US-based ACCME-accredited CME provider can use ACCME AMA PRA Category 1 Credits™ toward their credit requirements.
ABIM MOC:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.
Dr. Meah reports no financial relationships.
Dr. Wall reports the following financial relationships:
Consultant: Bristol Myers Squibb and Pfizer Inc. (on behalf of the National and International Skin Registry)
Grants/Research Support: Janssen Global Services, LLC and Pfizer Inc.
Other: National and International Skin Registry Solutions (Charity)
The following peer reviewer and CME Outfitters staff report no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
JC-023-061622-02